PhRMA Prods Japan to Harness Power of RWD in Drug Development, Medical Care Evaluation

February 3, 2021
Japan should create an environment to better harness real-world data (RWD) in its regulatory policymaking and business in the healthcare arena, easing restrictions on database access and integrating electronic medical records and insurance claims data, the Pharmaceutical Research and Manufacturers...read more